about
ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis5-ALA Patch-PDT of Actinic Keratosis on the Upper ExtremitiesA Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical GelA Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic KeratosesComparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis TreatmentLevulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal MicroscopyEfficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic KeratosisSafety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic KeratosisALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant RecipientsPhotodynamic Therapy-Induced Immune Modulation: Part IIITopical Ionic Contra-Viral Therapy in Actinic KeratosisAminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and PreventionIdentification of Compound From Brinjal Peel Extract in the Treatment of Palmar Arsenical Keratosis and Bowen's DiseaseStudy to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands1-Year Follow up to the 1473-IMIQ StudyStudy of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic KeratosesStudy to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic KeratosesT4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney TransplantAn A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic KeratosesMicrowave Therapy for Treatment of Precancerous Actinic KeratosesStudy to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic KeratosisPRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AKClinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged SkinA Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head LocationsPhotodynamic Therapy Incubation Times for Actinic KeratosisPhotodynamic Therapy of Actinic Keratoses With Alacare®A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and ScalpPhotodynamic Treatment of Actinic Keratoses With Different Light DosesCombination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin DiseaseImiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant RecipientsEfficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis TreatmentShort-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic KeratosesDevelopment and Validation of a Quality of Life Instrument for Actinic KeratosisSelenium in the Treatment of Arsenic Toxicity and CancersLAS41005 in Hyperkeratotic Actinic KeratosisIdentification of Compound Isolated From Cock's Comb and Its Effect on Arsenical Palmar Keratosis
P1050
Keratoderma blennorrhagicumparakeratosishyperkeratosisacquired hyperkeratosisKeratolytic winter erythemaOrthokeratosisseborrheic keratosisacrokeratosis verruciformisdisseminated superficial actinic porokeratosischolesteatomacallositykeratosis follicularisHydrocarbon keratosisKeratosis pharyngispalmoplantar keratosisThermal keratosis
P279
Q61894692-EFE6CE9E-0DC7-4ABF-B470-724169824D47Q61907251-92DD4DE0-6C6D-406D-A6AF-72EAB66D6B89Q61921383-C0876BE0-453B-4C34-A225-1F182AB66FFAQ61957537-E2AB298F-7932-4DD7-B639-8A239C5E3961Q61965789-B2DDAFD1-7FBF-47D9-A3CB-71EEA968891AQ61965861-E4AAAC85-E5A3-4C0C-AB4B-4245567D29F2Q61966944-DA58CFF5-93D1-421E-9BD1-E6791B0773F7Q61967580-B1FEA60C-84FD-44B1-AE2A-06F0E54503E2Q61969404-76C3C0D7-8C63-4F46-8782-CEC5D143CC9AQ61975711-51D87356-ECB1-4A72-98A6-24FE83E44151Q61975963-A475354A-6587-4310-B107-388345231EFFQ61981032-03A9385F-B466-495B-A379-41D2A324C499Q62025963-21447AC1-CD35-4F51-BDBE-146D71720B43Q62054631-6BADE8E4-DE3E-4590-957E-4E0E50160094Q62062776-C46120EA-8D41-441D-A32E-A670C7F0F751Q62062893-EBB70724-CEFB-4105-BAF2-8AB727E5968FQ62104795-8673927D-A734-4844-B715-C3F15702FE91Q62104901-3A175809-4E58-4144-8BD6-67CE4A3E5451Q62105232-D477AF2A-ED92-44B9-AD04-2A1AEAA1FB74Q62105569-C8979AC9-53A6-4DB4-9E1F-BF603991BAA0Q62110084-5075F875-400A-4E2C-B1BB-30F1E29A1647Q62808914-93893051-C282-4003-9255-BEC6C38D5B0BQ62810116-B232C58B-5497-450F-864D-98327BEF5137Q62812881-435E5A91-D452-4CA6-B044-B8998712BB84Q62820385-A822E044-62F8-4ECB-A7E1-2D0BB8502055Q62821731-D9C411B1-FC68-4F9F-9BC4-D87E77F94CC9Q63062590-04F1076D-E008-4344-8C3C-BDFAE7D6C37BQ63229422-198BD943-F2AC-4BF6-B367-8777C9459CCDQ63316611-8D54C3E7-F979-47CB-ADC1-12A429076E1CQ63318846-348AA681-612B-4FF4-AFD2-6B0C46691B27Q63318967-53777400-AAD4-4B19-AC57-2970AC07816DQ63318971-F82670B1-8BAF-4FD0-B91A-641B82C8B847Q63319686-0A623F45-EC60-4C0D-ADAC-080FDC63801AQ63319823-62D7F36D-5062-4DC8-A644-F304D0DDC39DQ63320927-1E5B4A44-C372-4B6B-928A-27F6CD9AEE37Q63321137-800666EA-8CBA-4D44-B082-EB349BD68B21Q63321727-5AB32A82-A5FB-4E82-AD3B-5032B193C9FDQ63322110-B09766ED-24BA-4D9B-B415-D21CD9B82D32Q63335898-F80F4E97-5F67-4A98-9FDD-5890DC01F588Q63394183-3C940921-F58A-444A-8D48-7E834FE4613C
P1050
Q12202899-38c19c64-49d7-bbf5-ef20-dc9386a4ca31Q1519657-b0406d86-40e9-b0a7-7880-a41ff8c1b130Q1640998-4cb62de4-4593-02e8-a1cb-43b70f623660Q18554424-2F463CEC-E7C4-47F2-B3F8-36F599A2BE62Q1976193-0f73f381-4bb7-cf07-6fa0-ec809250b363Q2031876-1f289c10-46f3-72ee-cbc3-52726fc4d82cQ2166371-2233CFB2-DA2E-4E72-90FB-79525C044543Q4675784-F88C2A54-A98D-417C-B24C-6A17BEEBE07AQ5282749-C31D4A19-5C68-45AF-961C-813105B109C9Q558230-FF99269D-CCA3-4177-8F55-376EA3EAF026Q579108-cce6ffeb-4ea9-dace-99d8-59425f3dd5acQ580506-89CC6661-F7F9-4C03-BD67-113D1FC1A280Q5954668-d08beb50-43ae-4869-2cb5-89d6e702b287Q6393659-b1ce7475-4c06-eebb-d76b-ecfea5ff4cf3Q7128426-B6A84D5B-9C48-445C-BB0C-CEE8A3D7372EQ7783059-2b3e579f-420a-66cb-a4a8-094388856322
P279
description
Enfermedad de la piel caracter ...... iel o en las membranas mucosas
@es
Krankheit
@de
Larruazaleko geruza korneoan sortzen den lodigunea
@eu
cura
@it
hypertrophie des couches cornées de l'épiderme
@fr
skin disease characterized by growth of keratin on the skin or mucous membranes
@en
ελαφρώς ή σημαντικά επηρμένες καλοήθεις κερατινοκυτταρικές βλάβες
@el
مرض بشري
@ar
name
Ceireatóis
@ga
Dày sừng
@vi
Keratoderma
@de
Keratoderma
@id
Keratosi
@eu
caleden
@cy
cheratosi
@it
keratose
@nn
keratosis
@en
kératose
@fr
type
label
Ceireatóis
@ga
Dày sừng
@vi
Keratoderma
@de
Keratoderma
@id
Keratosi
@eu
caleden
@cy
cheratosi
@it
keratose
@nn
keratosis
@en
kératose
@fr
altLabel
keratosis
@es
kératodermie
@fr
קרטוזיס
@he
קרטוסיס
@he
تقرن
@ar
prefLabel
Ceireatóis
@ga
Dày sừng
@vi
Keratoderma
@de
Keratoderma
@id
Keratosi
@eu
caleden
@cy
cheratosi
@it
keratose
@nn
keratosis
@en
kératose
@fr
P2176
P494
P2581
P486
P508
P6366
P672
P1417
science/keratosis